Annelise Segers

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob, Nick van Es, Peter Verhamme et al. · New England Journal of Medicine · 2017 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry R. Büller, Claudette Bethune, Sanjay Bhanot et al. · New England Journal of Medicine · 2014 · 622 citations · Full text

Medicine, Hematology, Molecular Genetics +11

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Harry R. Büller, Anthonie W.A. Lensing, Martin H. Prins et al. · Blood · 2008 · 345 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Abelacimab for Prevention of Venous Thromboembolism

Peter Verhamme, B. Alexander Yi, Annelise Segers et al. · New England Journal of Medicine · 2021 · 291 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

Harry R. Büller, David Deitchman, Martin H. Prins et al. · Journal of Thrombosis and Haemostasis · 2008 · 251 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13